Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer

The authors investigate how different p53 mutation statuses affect the expression and signaling of the type I interferon (IFN-I) pathway in endometrial cancer. Their findings reveal that p53mut overexpressed tumors exhibit heightened IFN-I pathway component expression, indicative of a chronic inflammatory state, while p53mut null tumors show reduced expression, suggesting an immunosuppressed environment. These results highlight the potential role of p53 mutations in modulating immune responses in endometrial cancer and suggest avenues for further research.